DE69201559D1 - Pyrimidinderivate zur erhöhung der antitumoraktivität. - Google Patents

Pyrimidinderivate zur erhöhung der antitumoraktivität.

Info

Publication number
DE69201559D1
DE69201559D1 DE69201559T DE69201559T DE69201559D1 DE 69201559 D1 DE69201559 D1 DE 69201559D1 DE 69201559 T DE69201559 T DE 69201559T DE 69201559 T DE69201559 T DE 69201559T DE 69201559 D1 DE69201559 D1 DE 69201559D1
Authority
DE
Germany
Prior art keywords
oractivity
antitum
increasing
pyrimidine derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69201559T
Other languages
English (en)
Other versions
DE69201559T2 (de
Inventor
Jotham Coe
Anton Fliri
Takushi Kaneko
Eric Larson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69201559D1 publication Critical patent/DE69201559D1/de
Publication of DE69201559T2 publication Critical patent/DE69201559T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
DE69201559T 1991-04-17 1992-03-30 Pyrimidinderivate zur erhöhung der antitumoraktivität. Expired - Fee Related DE69201559T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68689991A 1991-04-17 1991-04-17
PCT/US1992/002434 WO1992018498A1 (en) 1991-04-17 1992-03-30 Pyrimidine derivatives for enhancing antitumor activity

Publications (2)

Publication Number Publication Date
DE69201559D1 true DE69201559D1 (de) 1995-04-06
DE69201559T2 DE69201559T2 (de) 1995-07-13

Family

ID=24758194

Family Applications (2)

Application Number Title Priority Date Filing Date
DE9290039U Expired - Lifetime DE9290039U1 (de) 1991-04-17 1992-03-30 Pyrimidinderivate zur Verbesserung der Anti-Tumor-Aktivität
DE69201559T Expired - Fee Related DE69201559T2 (de) 1991-04-17 1992-03-30 Pyrimidinderivate zur erhöhung der antitumoraktivität.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE9290039U Expired - Lifetime DE9290039U1 (de) 1991-04-17 1992-03-30 Pyrimidinderivate zur Verbesserung der Anti-Tumor-Aktivität

Country Status (22)

Country Link
EP (1) EP0580753B1 (de)
JP (1) JPH0819121B2 (de)
CN (1) CN1065863A (de)
AT (1) ATE119157T1 (de)
AU (1) AU653601B2 (de)
BR (1) BR9205906A (de)
CA (1) CA2108561A1 (de)
CZ (1) CZ390992A3 (de)
DE (2) DE9290039U1 (de)
DK (1) DK0580753T3 (de)
ES (1) ES2068714T3 (de)
FI (1) FI934565A (de)
GR (1) GR3015921T3 (de)
HU (1) HUT65177A (de)
IE (1) IE64915B1 (de)
MX (1) MX9201763A (de)
NO (1) NO933722D0 (de)
NZ (1) NZ242390A (de)
PT (1) PT100386A (de)
WO (1) WO1992018498A1 (de)
YU (1) YU39992A (de)
ZA (1) ZA922815B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188411B (de) 1997-03-27 2002-09-21 Yuhan Corp
US6440965B1 (en) * 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
US6593322B1 (en) 1999-03-17 2003-07-15 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
AU766648B2 (en) 1999-03-17 2003-10-23 Axys Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
US6630469B2 (en) * 2000-05-09 2003-10-07 Bristol-Myers Squibb Company 5-HT7 receptor antagonists
US7205297B2 (en) 2000-07-24 2007-04-17 Krenitsky Pharmaceuticals, Inc. Substituted 5-alkynyl pyrimidines having neurotrophic activity
JP2005232081A (ja) * 2004-02-19 2005-09-02 Bayer Cropscience Ag ベンジルピリミジン誘導体の農園芸用殺菌剤としての利用
JP2010111702A (ja) 2009-02-16 2010-05-20 Tetsuya Nishio 複素環化合物、その製造法および用途
CN103333119A (zh) * 2013-05-28 2013-10-02 中国药科大学 1,2-二氢-6-甲基-4-取代氨基-5-嘧啶羧酸类化合物及其制备方法和用途
CN115232076A (zh) * 2022-07-25 2022-10-25 南通大学 苯氨基取代的嘧啶氨基酸衍生物及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2744663B2 (ja) * 1988-12-29 1998-04-28 三井化学株式会社 ピリミジン類及びその薬学的に許容される塩類
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
WO1992018498A1 (en) 1992-10-29
NZ242390A (en) 1994-09-27
AU1776192A (en) 1992-11-17
CN1065863A (zh) 1992-11-04
FI934565A0 (fi) 1993-10-15
BR9205906A (pt) 1994-07-05
IE64915B1 (en) 1995-09-20
NO933722L (no) 1993-10-15
YU39992A (sh) 1995-01-31
HUT65177A (en) 1994-05-02
ES2068714T3 (es) 1995-04-16
FI934565A (fi) 1993-10-15
AU653601B2 (en) 1994-10-06
JPH0819121B2 (ja) 1996-02-28
CA2108561A1 (en) 1992-10-18
EP0580753B1 (de) 1995-03-01
ZA922815B (en) 1993-10-18
IE921214A1 (en) 1992-10-21
DE9290039U1 (de) 1993-12-09
EP0580753A1 (de) 1994-02-02
DE69201559T2 (de) 1995-07-13
MX9201763A (es) 1992-10-01
ATE119157T1 (de) 1995-03-15
PT100386A (pt) 1993-06-30
GR3015921T3 (en) 1995-07-31
NO933722D0 (no) 1993-10-15
HU9302929D0 (en) 1993-12-28
JPH06501023A (ja) 1994-01-27
DK0580753T3 (da) 1995-07-03
CZ390992A3 (en) 1994-03-16

Similar Documents

Publication Publication Date Title
DK0572437T3 (da) 2,4-diaminoquinazolinderivater til forøgelse af antitumorvirkning
YU47993B (sh) Derivati 2,4-diaminohinazolina
GR3036250T3 (en) Pyrimidine or triazine derivatives and herbicidal composition containing the same.
DE69201559D1 (de) Pyrimidinderivate zur erhöhung der antitumoraktivität.
DE69110093D1 (de) Pyrimidinderivate.
GR1001386B (el) Ετεροκυκλικές ενώσεις.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee